IGF1R and cancer: In conclusion, a molecular design of the ZIGF-1R:4551 affibody molecule that includes the placement of the (HE)3-tag at N-terminus and site-specific coupling of a NODAGA chelator at C-terminus provides a tracer with improved imaging properties for the visualization of IGF-1R expression in malignant tumors when using PET and SPECT modalities.